Darvocet Heart Attack Lawsuit Filed Over Death of Mother

A Louisiana woman’s family has filed a Darvocet lawsuit against Eli Lilly, Xanodyne Pharmaceuticals and other companies that distributed the drug, saying the recalled painkiller caused her to suffer a fatal heart attack. 

The complaint was filed on May 24 in U.S. District Court in New Orleans by Peggy Oniate, Elizabeth Frederick and Andrew Houlihan Jr. against Eli Lilly & Co., Xanodyne Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Qualitest Pharmaceuticals Inc. and Vintage Pharmaceuticals, Inc. The lawsuit indicates that Elizabeth Houlihan died of a heart attack in May 2010, which was allegedly caused by side effects of Darvocet.

The lawsuit is one of a growing number that have been filed by plaintiffs who say they suffered heart problems or lost loved ones due to a heart attack from Darvocet.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Next month, a panel of federal judges is scheduled to hear arguments over whether the Darvocet litigation should be consolidated under one federal judge as part of an MDL, or multidistrict litigation.

The plaintiffs seek to have the cases consolidated since all lawsuits over Darvocet, Darvon and other propoxyphene-based painkillers contain similar allegations, that drug makers failed to warn doctors and patients about the risk of serious and potentially fatal heart rhythm problems.

Darvocet was a popular pain medication that combines acetaminophen with propoxyphene, the active ingredient in the similar painkiller Darvon. It was sold by Eli Lilly for about 40 years before distribution rights for the name brand version of the drug were sold to AAIPharma in 2002, and it was subsequently purchased by Xanodyne in 2005.

In November 2010, a Darvon and Darvicet recall was announced after the FDA concluded that side effects of Darvocet and Darvon can cause significant changes to the electrical activity of the heart.  The heart problems may increase the risk of heart arrythmias, myocardial infarction and sudden death. Both the brand name drugs and their generic equivalents were pulled from the market.

The Darvocet heart attack lawsuit filed by Elizabeth Houlihan’s family seeks damages for medical expenses, funeral expenses, pain and suffering, loss of a loved one, and loss of services.

3 Comments

  • MelissaSeptember 13, 2024 at 8:53 pm

    My mother died while taking dark over in 2005

  • SheriNovember 14, 2011 at 11:55 pm

    My father was talking a energy pill that contained the same ingreidents. and within a year he suffered a fatal heart attack, that was a result of arrythmia. that resulted in micardial infartion. he was 58 years old. this happened in 1989. the energy pill was called Quik Pep.

  • rhondaJune 20, 2011 at 11:09 pm

    I was prescribed darvocet all thru 70's & 80's.I dave very high bloodpressure,heart rasing,everything but a heartattech since 2005.i son't know if i qualify?

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Silicosis Lawsuit Filed Against Artificial Stone Manufacturers, Distributors
Silicosis Lawsuit Filed Against Artificial Stone Manufacturers, Distributors (Posted today)

An artificial stone countertop fabricator and installer has filed a lawsuit after he developed a debilitating lung disease, known as silicosis, alleging that manufacturers failed to protect workers from inhaling dangerous amounts of silica dust.

BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal
BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal (Posted 4 days ago)

Days after the FDA announced a BioZorb recall, an Arkansas woman has filed a lawsuit, indicating that her BioZorb tissue marker migrated out of position, causing pain and disfigurement, instead of harmlessly absorbing into the body as advertised.